advertisement
|
|
|
|
|
advertisement
|
|
Top Stories
The agency has approved three applications for generic versions of Gilenya (fingolimod), Novartis’ blockbuster multiple sclerosis drug.
/ read more /
The acquisition aids in the expansion of the Astellas Focus Area approach, which involves the creation of medicines for diseases with high unmet medical needs by identifying combinations of biology, therapeutic modality and technology based on emerging science.
/ read more /
|
|
|
|
advertisement
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers
|
 |
|
|
PRODUCT SPOTLIGHT |
 |
Put our labware through its paces
Only the best laboratory glassware meets USP, EP and ASTM quality standards. That’s all DWK sells! Store your formulations with security in containment solutions by DWK Life Sciences. Ask your rep in for a special offer – discount prices and more!
/ click here to learn more / |
|
|
|
Industry News
Expert poll highlights strength of US pharma sector and advances by emerging markets.
/ read more /
Horizon Discovery has announced its partnership with the Human Protein Atlas, which will see the incorporation of Horizon’s CRISPR-edited knockout cell models into the Cell Atlas program.
/ read more /
More Industry News
|
|
|
|
advertisement
|
|
|
Supplier News
GE Healthcare Life Sciences and Advanced Solutions Life Sciences (ASLS) are partnering on 3D-printing of tissues that can be used for discovery and cytotoxicity testing.
/ read more /
Cambrex reports that the acquisition by the investment group will facilitate ongoing growth.
/ read more /
More Supplier News
Regulatory News
The app, CURE ID, is designed to allow the clinical community to report their experiences treating infectious diseases with novel uses of existing FDA-approved drugs.
/ read more /
FDA’s Office of New Drugs restricting aims to improve scientific exchange and information sharing among review professionals.
/ read more /
More Regulatory News
| Bio/Pharma News
GE Healthcare Life Sciences and Guangzhou Development District Investment Promotion Bureau have signed an agreement to jointly establish a training center for biopharmaceutical professionals.
/ read more /
Iontas has entered into a collaboration agreement with Adaptate Biotherapeutics for the generation and optimization of antibodies for novel immune-oncology targets.
/ read more /
More Bio/Pharma News
advertisement
advertisement
|
Featured Topics |
|
ANALYTICS
Close collaboration between academic and industrial groups is vital to ensuring glycosylation models are fit for deployment.
/ read more /
|
|
|
QUALITY SYSTEMS
Given the complexity of different pharmacopoeias around the world, this fifth article in a series takes a closer look at ongoing efforts to harmonize compendial standards, with perspective that may be helpful in considering the future direction of pharmacopoeias.
/ read more /
|
|
|
| |
|
EXCIPIENTS
Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.
/ read more /
|
|
|
SUPPLY CHAIN
Novartis, BMS, and other companies are reducing complexity by thinning out product portfolios. Reducing complexity can reduce waste and improve responsiveness, but it must be done right.
/ read more /
|
|
|
Events
January 15–16, 2020
January 20–21, 2020
February 5–6, 2020
more events
|
|
|
eBOOKS
 |
The editors explore novel technologies for the formulation, manufacture,
purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.
|
|
|
|
|
|
Learn More
Learn More
Learn More